 - Patients must have histologically confirmed recurrent MBPNET that is a first relapseprogression after completion of definitive radiotherapy - craniospinal irradiation. Patients with a first relapseprogression who are unable to receive radiation therapy due to genetic disorders that put them at significant risk for radiation-induced secondary malignancies ie. Gorlins syndrome or NF1 mutation are eligible for enrollment. 